Medical Devices
Glucotrack Advances Continuous Blood Glucose Monitor with First Human Trial Success
Glucotrack has completed a groundbreaking first-in-human study of its intravascular continuous blood glucose monitor, demonstrating safety and technical feasibility for insulin-dependent diabetes patients. The successful trial paves the way for a comprehensive long-term clinical evaluation.
Nutriband Develops Innovative Abuse-Deterrent Fentanyl Patch to Address Opioid Crisis
Nutriband Inc. has developed AVERSA™ Fentanyl, a technologically advanced transdermal patch designed to provide effective pain management while mitigating potential opioid abuse risks. The innovation represents a strategic approach to addressing the ongoing public health challenge of the opioid epidemic.
SeaStar Medical Achieves Six FDA Breakthrough Device Designations, Promising New Hope for Critical Care Patients
SeaStar Medical has secured six FDA Breakthrough Device Designations for its Selective Cytopheretic Device (SCD) therapy, targeting life-threatening conditions with limited treatment options. These designations highlight the potential to transform care for patients with acute kidney injury, inflammatory responses, and other critical health challenges.
Femto Technologies Secures Patent Allowance for Innovative Sensera Wellness Device
Femto Technologies Inc. received a Notice of Allowance from the USPTO for its Sensera device design, highlighting a significant milestone in AI-driven female wellness technology that was recently honored with a CES Innovation Award.
SeaStar Medical Advances Kidney Injury Treatment with Innovative Pediatric Therapy
SeaStar Medical's QUELIMMUNE therapy offers promising treatment for pediatric acute kidney injury, with FDA approval and early hospital adoption signaling potential breakthrough in a critical healthcare challenge.
Nutriband Advances Abuse-Deterrent Fentanyl Patch in Response to Opioid Crisis
Nutriband is developing an innovative abuse-deterrent transdermal fentanyl patch amid shifting FDA regulations and ongoing efforts to combat opioid misuse. The technology represents a potential breakthrough in safer pain management strategies.
Hydromer Reports Q1 Revenue Decline Amid Strategic Reinvestment
Medical coatings company Hydromer experienced a revenue and earnings decrease in Q1 2025, yet remains committed to strategic investments and long-term growth in the medical device technology sector.
Femto Technologies Secures Patent for Smart Release System Technology in Femtech Innovation
Femto Technologies has received a Notice of Allowance from the U.S. Patent and Trademark Office for its proprietary Smart Release System technology, reinforcing its position as an AI-driven feminine wellness innovator and highlighting the potential for advanced technology in personal health solutions.
HeartBeam Expands Patent Portfolio with Innovative Cardiac Monitoring Technologies
Medical technology company HeartBeam adds two new U.S. patents to its intellectual property collection, enhancing its capabilities in portable cardiac monitoring and arrhythmia detection technology.
HeartBeam Expands Board with CEO Robert Eno's Appointment
HeartBeam Inc. strengthens its leadership by appointing CEO Robert Eno to its Board of Directors, signaling strategic preparation for the commercial launch of its innovative 3D ECG technology.
HeartBeam to Host Q1 2025 Financial Results Conference Call, Spotlight Cardiac Innovation
Medical technology company HeartBeam will provide a comprehensive business update and first-quarter financial results, highlighting its potential to revolutionize cardiac health monitoring through innovative portable diagnostic technology.
United Health Products Faces FDA Hurdle in Medical Device Approval Process
United Health Products navigates regulatory challenges while achieving OTCQB market uplisting, signaling potential strategic shifts in its medical technology development efforts.
Monogram Technologies Receives Indian Regulatory Approval for Robotic Knee Surgery Clinical Trial
Monogram Technologies has secured regulatory approval to conduct a multi-center clinical trial in India for its mBôs TKA robotic total knee replacement system, marking a significant step toward potential commercial launch and advancement in orthopedic surgical technology.
Nutriband Advances Abuse-Deterrent Transdermal Drug Technology, Eyes 2025 Commercialization
Nutriband is positioning itself for potential market expansion by developing innovative abuse-deterrent transdermal pharmaceutical products with projected peak annual sales exceeding $330 million for its Fentanyl and Buprenorphine patches.
HeartBeam Advances Portable 12-Lead ECG Technology with Promising Clinical Study Results
Medical technology company HeartBeam demonstrates high diagnostic accuracy for its innovative credit card-sized ECG device, potentially revolutionizing remote cardiac monitoring and patient care.
Nephros Unveils S100 In-Line Microfilter for Expanded Water Safety Solutions
Nephros launches a versatile S100 In-Line microfilter that enhances bacterial retention capabilities across various low-pressure environments, offering more flexible water filtration options for medical, clinical, and commercial settings.
Nutriband Develops Innovative Abuse-Deterrent Transdermal Drug Technology
Nutriband Inc. is advancing pharmaceutical safety through its AVERSA technology, which aims to prevent drug abuse and misuse in transdermal patches while maintaining patient access to critical medications.
Medtronic Faces Major Legal Challenge in Insulin Pump Defect Lawsuit
A California court has denied Medtronic's Motion for Summary Judgment in two separate lawsuits, finding potential evidence of fraudulent concealment regarding defective insulin pump retainer rings that could impact thousands of Type-I diabetics.
HeartBeam and AccurKardia Partner to Advance Remote ECG Monitoring Technology
Medical technology firm HeartBeam collaborates with AccurKardia to integrate advanced ECG analysis software into a cable-free 12-lead ECG device, potentially transforming remote cardiac care and diagnosis.
Medical Device Experts to Convene in Philadelphia for Usability Congress
Dynamic Global Events will host a critical conference focused on human factors engineering and usability studies in medical device design, bringing together industry professionals to address complex regulatory and design challenges in healthcare technology.
KERDOM Unveils Ultra-Lightweight Electric Wheelchair Designed for Maximum Mobility and Travel
KERDOM introduces the E100L (Model DX04), an innovative electric wheelchair that offers unprecedented portability and flexibility for users seeking enhanced mobility. The device promises to transform personal transportation for seniors and individuals with mobility challenges through its compact design and advanced features.
Global Brain Tumor Treatment Market Projected to Reach $7.15 Billion by 2035
The brain tumor treatment market is expected to experience substantial growth, driven by advances in medical technologies like immunotherapy and personalized medicine. The market's projected 7.2% compound annual growth rate signals significant potential for medical innovation and investment.
Life Science Investment Leader Michael Ryan Joins Sigyn Therapeutics Board Amid Blood Purification Tech Development
The appointment of Michael Ryan, founder of Ireland's largest angel investment syndicate, to Sigyn Therapeutics' Board of Directors strengthens the company's position in developing crucial blood purification technologies for treating life-threatening conditions.
AI Healthcare Firm Advances FDA Approval Process for Vision AI Platform to Detect Diabetic Retinopathy
Avant Technologies has initiated funding preparations for Ainnova's FDA approval process of their Vision AI platform, marking a significant step toward bringing AI-powered early disease detection technology to the U.S. healthcare market.
Therma Bright Secures Major Distribution Deals as Compression Therapy Market Set to Hit $6.72B
Medical device company Therma Bright has secured significant distribution agreements and Medicare reimbursement approvals for its Venowave VW5 compression device, positioning itself for substantial growth in the rapidly expanding compression therapy market.
United Health Products Advances FDA Approval Process for Novel Hemostatic Agent
Medical device company United Health Products has made significant progress in its FDA approval process for CelluSTAT, a natural bleeding control agent, while securing funding and pursuing an uplisting to OTCQB. The development could lead to a new option in surgical bleeding control.
Therma Bright Secures Major Distribution Deals for Medicare-Approved Compression Device
Medical device company Therma Bright has secured significant purchase orders for its Venowave VW5 compression device, marking a substantial expansion in the $4.2 billion compression therapy market following Medicare approval and reimbursement authorization.